SIRT1 and cancer: Furthermore, this review underscores the coexistence of unresolved mechanistic uncertainties and therapeutic opportunities, while highlighting the dual identity of SIRT1 as both a longevity factor and an oncogenic driver, offering a novel framework that links redox biology, cancer adaptation, and therapeutic resistance [11].